News about

Earnings Scheduled For March 13, 2013

Wed, 13 Mar 2013 04:21:27 -0400

Accretive Health (NYSE: AH) is expected to report its Q4 earnings at $0.09 per share on revenue of $236.87 million.

Elbit Systems (NASDAQ: ESLT) is estimated to report its Q4 earnings at $0.88 per share on revenue of $838.40 million.

Discovery Laboratories (NASDAQ: DSCO) is projected

BG Medicine Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients

Wed, 27 Feb 2013 08:40:28 -0500

BG Medicine, Inc. (Nasdaq: BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, announced today the publication of two studies demonstrating the clinical utility of repeated galectin-3 testing as a tool in the assessment of patients with heart failure. The studies, which together involved more than 3,300 subjects,

BG Medicine Announces Offering of Common Stock

Thu, 24 Jan 2013 16:36:37 -0500

BG Medicine, Inc. (Nasdaq: BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. BG Medicine also expects to grant the underwriters a 30-day option to purchase additional shares of common

Benzinga's Small Cap Movers for Thursday January 3, 2013

Thu, 03 Jan 2013 19:42:28 -0500

Below are highlights from Benzinga's daily coverage of small cap securities making big moves:

BG Medicine

Shares of BG Medicine (NASDAQ: BGMD), the Waltham, MA company focused on the development and commercialization of novel cardiovascular diagnostics, rose 18% Thursday on 5 times average volume.

BG Medicine announced Wednesday that the first

Morning Market Movers

Wed, 12 Dec 2012 09:53:09 -0500

DayStar Technologies (NASDAQ: DSTI) surged 86.16% to $2.2710 at 9:45 am. Former US Secretary of Energy, former Governor of New Mexico and Nobel Prize nominee, Bill Richardson, has joined the Board of Directors of DayStar Technologies.

YM BioSciences (AMEX: YMI) climbed 77.91% to $2.90. YM BioSciences agreed to be

Benzinga's Small Cap Movers for Tuesday December 11, 2012

Tue, 11 Dec 2012 19:09:23 -0500

Below are highlights from Benzinga's daily coverage of small cap securities making big moves:

BG Medicine

Shares of BG Medicine (NASDAQ: BGMD), the Waltham, MA diagnostics company, rose 154% Tuesday on 53 times average volume.

BG Medicine announced Tuesday that it has obtained a CE Mark enabling the commercial sale of

Top Narrow Based Indexes For December 11, 2012

Tue, 11 Dec 2012 10:42:11 -0500

By 10:38 am, the Dow Jones Industrial Average was up 93.50 points, or 0.71%, to 13,263.38, while the broader Standard & Poor's 500 index had gained 11.44 points, or 0.81%. The NASDAQ composite index rose 36.74 points, or 1.23%.

Some of the narrow based indexes that are driving the markets

BG Medicine-BSX Engages In Research

Fri, 01 Apr 2011 15:05:22 -0400

Recently, BG Medicine (BGMD) entered in a research collaboration agreement with leading medical devices player, Boston Scientific Corporation (NYSE:BSX). The two companies will study the role of galectin-3 to help screening of patients who would derive the maximum benefit from the cardiac-resynchronization therapy (CRT) and would use patient data from the MADIT-CRT trial. CRT is [...]